“…clinopodioides (0.2%) [184] Synergistic antibacterial activity with ampicillin against strain of S. aureus [383] Z. tenuior [94] Caryophyllene oxide (β-caryophyllene oxide) (90) Z. clinopodioides (0.5%) [184] Antitermitic [187], antifungal [308,384], antimicrobial [385] Analgesic and anti-inflammatory activity in tested mice [386] Modest cytotoxic activity against tested human tumor cell lines [387] Anti-cancer effects through the modulation of the PI3K/AKT/mTOR/S6K1 and MAPK signalling [388] O H H Z. tenuior (0.11%-0.32%) [94,179,202] Caryophyllene (syn. β-caryophyllene, trans-caryophyllene, (E)-caryophyllene) (91) Z. tenuior (0.22%) [94,179] Antifungal, antibacterial [187] Antiprotozoal (T. cruzi, L. infantum) [389] Fumigant against Lasioderma serricorne [390] Antihyperglycemic effect by decreasing blood glucose and increasing plasma insulin in diabetic rats [391] Antioxidant effect and inhibition of 5-lipoxygenase in CCl4-induced fibrosis in rats [392] Anti-inflammatory effect through the inhibition of TNFα and PGE2 and it is also effective in reducing PAF-, bradykinin-, ovoalbumin-induced mouse paw edema [393,394] Low inhibition of acetylcholinesterase and butyrylcholinesterase [224] Review on metabolism and toxicity [200] H H α-Humulene (syn. α-Caryophyllene) (92) Z. clinopodioides (2.7%-4.5%) [184] Antibacterial activity against Propionibacterium acnes (MIC of 3.13 µg/mL) [395] Antiproliferative activity against several cancer cell lines (MCF-7, PC-3, M4BEU, CT-26, human amelanotic melanoma cell line C32, renal cell adenocarcinoma ACHN, hormonedependent prostate carcinoma LNCaP, A-549 and human colon adenocarcinoma cell line DLD-1) [396][397][398]…”